BridgeMD
New treatment option for Borrelia Burgdorferi Neuroborreliosis
Official title 64Cu-DOTATATE-PET for Lyme Neuroborreliosis
ClinicalTrials.gov ID: NCT06392815
What this study is testing
- What it's testing
- The aim of the study is to investigate the applicability and performance of 64Cu-DOTATATE PET/CT/MR for diagnosis in patients with Lyme neuroborreliosis (LNB). In this prospective, observational cohort study with 64Cu-DOTATATE, the investigators wish to include a total of 50 patients clinically suspected of LNB.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- Age ≥ 18 years AND
- Clinical suspicion of LNB AND
- Must be able to read and understand the patient information and to give informed consent -
You likely can't join if
- Pregnancy OR
- Breast-feeding OR
- Concluded antibiotic treatment OR
- Weight more than the maximum weight limit for the PET/CT/MRI bed of the scanner (140 kg) OR
- History of allergic reaction attributable to compounds of similar chemical or biologic composition to 64Cu-DOTATATE OR
- Contraindications to MR (check list) -
The study team makes the final eligibility decision.
Where it's taking place
- Copenhagen, Capital Region, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Copenhagen, Capital Region, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.